New guidelines recommended for diagnosis and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) can assist doctors in taking care of patients.
New Cellular Approach To Help Control Chronic Kidney Disease
Study provides new insights about the mechanisms of kidney disease and point to a new approach for improved treatments.
Study provides new insights about the mechanisms of kidney disease and point to a new approach for improved treatments.
‘Recommendations for treatment of Chronic kidney disease-mineral and bone disorder (CKD-MBD) have been updated.’
A synopsis of the guidelines is published in Annals of Internal Medicine. CKD is defined as abnormalities in kidney structure or function that are present for more than 3 months and have health implications.
As kidney function decreases, marked changes in bone mineral metabolism occur, resulting in increased risk for fractures, cardiovascular disease, and overall mortality.
DNA Sequencing To The Rescue in Diagnosing Chronic Kidney Disease
The precise cause of kidney failure and identification of those at risk can now be done with DNA sequencing.
The precise cause of kidney failure and identification of those at risk can now be done with DNA sequencing.
The target audience for the synopsis includes nephrologists, primary care physicians, and other health professionals caring for adults with CKD or those receiving dialysis.
Advertisement
TCA Cycle Metabolites Found to be Altered in Chronic Kidney Disease
A group of molecules called Tri-Carboxylic Acid (TCA) cycle metabolites are significantly affected in chronic kidney disease.
A group of molecules called Tri-Carboxylic Acid (TCA) cycle metabolites are significantly affected in chronic kidney disease.
Source-Eurekalert
Sertraline Not Effective for Chronic Kidney Disease Patients
Standard anti-depressant sertraline may not be effective for major depressive disorder in patients with non–dialysis-dependent chronic kidney disease.
Standard anti-depressant sertraline may not be effective for major depressive disorder in patients with non–dialysis-dependent chronic kidney disease.
